Kevin Hoveida
Nephrology · San Diego, CANPI 1508931023
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.7% of the total across 77 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 23 manufacturers, the largest accounting for just 19.1% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $2,821 and has fallen 95.6% since, to $125 in 2025.
Across 77 payments — averaging $85.94 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson$1K
- Lilly USA, LLC$1K
- Acadia Pharmaceuticals Inc$799
- AstraZeneca$617
- UCB, Inc.$374
- CMP Pharma, Inc.$254
- plus $2K from 17 others
What the payments were for
- Travel & lodging$220%
- Food & beverage$6,595100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson | 12 | $1,267 |
| Lilly USA, LLC | 26 | $1,070 |
| Acadia Pharmaceuticals Inc | 8 | $799 |
| AstraZeneca | 5 | $617 |
| UCB, Inc. | 3 | $374 |
| CMP Pharma, Inc. | 2 | $254 |
| Sunovion Pharmaceuticals Inc. | 2 | $245 |
| Neurocrine Biosciences, Inc. | 2 | $245 |
| Bayer | 2 | $240 |
| Teva Pharmaceuticals USA, Inc. | 2 | $160 |
| Boston Scientific | 1 | $138 |
| Mylan Specialty L.p. | 1 | $124 |
| Radius Health, Inc. | 1 | $122 |
| Pfizer | 1 | $118 |
| Portola Pharmaceuticals, LLC | 1 | $114 |
| Novartis | 1 | $114 |
| Tetraphase Pharmaceuticals, Inc. | 1 | $113 |
| Sumitomo Pharma America, Inc. | 1 | $113 |
| Avanir Pharmaceuticals, Inc. | 1 | $107 |
| Sanofi-aventis U.S. LLC | 1 | $96 |
| Stryker | 1 | $89 |
| OPKO Pharmaceuticals, LLC | 1 | $58 |
| Scilex Pharmaceuticals Inc. | 1 | $42 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$6,617 in reported general payments places this provider in the 80th percentile of 1,341 nephrology providers in California.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 26 | $7,761 |
| JanuviaSitagliptin Phosphate | 16 | $4,461 |
| MyrbetriqMirabegron | 13 | $2,898 |
| Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog | 34 | $2,772 |
| Brimonidine Tartrate-TimololBrimonidine Tartrate/Timolol | 12 | $2,099 |
| Mirtazapine | 26 | $523 |
| Sucralfate | 12 | $367 |
| Potassium Chloride | 12 | $358 |
| Atorvastatin Calcium | 40 | $337 |
| Metformin Hcl | 39 | $302 |
| Famotidine | 32 | $279 |
| Amlodipine Besylate | 39 | $244 |
| Gabapentin | 22 | $240 |
| Baclofen | 12 | $231 |
| Quetiapine Fumarate | 15 | $225 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $118 | $7,76126 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 1,341 nephrology providers in California.
Other nephrology in San Diego
- Ravindra MehtaSan Diego$184K
- Ambarish AthavaleSan Diego$83K
- Juan QuevedoSan Diego$53K
- Anjay RastogiLos Angeles$2.2M
- Glenn ChertowStanford$2M
- Luis AlvarezPalo Alto$1.8M
- Jose MorfinSacramento$1M
- Rodolfo BatarseRancho Mirage$910K
- Vandana MathurWoodside$769K
- Yasir QaziOrange$618K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.